Plus Therapeutics, Inc.
PSTV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $13,289 | $2,233 | $9,867 | $76 |
| Short-Term Investments | $0 | $4,646 | $0 | $3,530 |
| Receivables | $0 | $1,021 | $0 | $571 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4,297 | $446 | $444 | $1,082 |
| Total Curr. Assets | $17,586 | $9,214 | $10,868 | $5,259 |
| Property Plant & Equip (Net) | $293 | $318 | $362 | $521 |
| Goodwill | $372 | $372 | $372 | $372 |
| Intangibles | $374 | $401 | $435 | $469 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $45 | $45 | $19 | $12 |
| Total NC Assets | $1,084 | $1,136 | $1,188 | $1,374 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $18,670 | $10,350 | $12,056 | $6,633 |
| Liabilities | – | – | – | – |
| Payables | $0 | $6,359 | $9,222 | $9,474 |
| Short-Term Debt | $21 | $0 | $0 | $3,292 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $13,595 | $927 | $1,297 | $2,741 |
| Total Curr. Liab. | $13,616 | $7,316 | $10,559 | $15,551 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $25,138 | $0 |
| Total NC Liab. | $0 | $0 | $25,138 | $31 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $21 | $30 | $40 | $75 |
| Total Liabilities | $13,616 | $7,316 | $35,697 | $15,582 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $132 | $92 | $17 | $6 |
| Retained Earnings | -$510,152 | -$505,729 | -$510,880 | -$493,479 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $515,074 | $0 | $0 | $0 |
| Total Equity | $5,054 | $3,034 | -$23,641 | -$8,949 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $18,670 | $10,350 | $12,056 | $6,633 |
| Net Debt | -$13,268 | -$2,233 | -$9,867 | $3,216 |